A Region-Delineated Snrna-Seq Atlas Of Mouse Spinal Cord Across Lifespan Resolves The Interaction Of Normative Aging Programs With Sod1-G93A ALS
Aging is the biggest risk factor for a devastating disease called Amyotrophic Lateral Sclerosis, or ALS, which causes nerve cells to progressively die. However, exactly how the natural process of aging influences the development and progression of ALS has been a mystery.
To shed light on this, scientists developed a comprehensive “atlas” of the mouse spinal cord. This atlas maps the activity of genes within individual cell nuclei—the control centers of cells—across the entire lifespan of healthy mice, from development to old age. They also included data from a specific mouse model of ALS, known as SOD1-G93A, which carries a mutated gene linked to the human form of the disease. This allowed them to compare normal aging patterns with changes seen in ALS.
One key finding was that the levels and forms of genetic material (transcripts) and proteins related to the SOD1-G93A mutation varied significantly in different parts of the spinal cord as the disease progressed. These regional differences mirrored how some areas of the spinal cord were more resistant to degeneration, while others were highly vulnerable. Before the disease even started, they found a reduction in a small protein called ubiquitin, which is crucial for maintaining a healthy balance of proteins within cells (a process called proteostasis). This reduction seemed to set the stage for problems with protein balance in specific spinal cord regions.
Interestingly, the study showed that the overall patterns of gene activity associated with aging remained largely normal in most cell types, suggesting that ALS doesn’t simply speed up the aging process across the board. However, one type of immune cell in the brain and spinal cord, called microglia, was a notable exception. These cells displayed accelerated and altered aging-related gene activity, controlled by specific regulatory proteins, indicating they play a unique and critical role in how aging and ALS interact. These discoveries provide a much clearer picture of how aging and disease pathways combine to cause nerve cell dysfunction and death in ALS.
Source: link to paper